Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
World's largest pet company with $22B+ revenue across Pedigree, Whiskas, Royal Canin, Banfield Pet Hospitals, and VCA; Mars family-owned competing with Nestlé Purina across nutrition and veterinary care.
Mars Petcare is the world's largest pet nutrition and veterinary healthcare company — a division of Mars, Incorporated (the private family-owned global confectionery and food conglomerate) producing market-leading pet food brands including Pedigree (dog food), Whiskas (cat food), Royal Canin (premium veterinary prescription nutrition), Iams, Sheba, Cesar, and Temptations, while also operating the Banfield Pet Hospital chain (1,000+ locations), VCA Animal Hospitals (1,000+ locations), BluePearl Veterinary Partners (specialty and emergency hospitals), and Antech Diagnostics (veterinary laboratory services). Mars Petcare generates estimated revenues of $22+ billion annually.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.